Home
News
Create
Screeners
Insights
Vanta Bioscience
18.
20
-0.02
(-0.11%)
Market Cap
₹12.99 Cr
PE Ratio
-0.97
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.11%
1M
+4.60%
6M
-28.82%
1Y
-24.79%
5Y
-89.79%
View Company Insights
Latest news about Vanta Bioscience
Vanta Bioscience Limited Submits SEBI Compliance Certificate for Q4FY26
8 days ago
Vanta Bioscience Limited submitted its SEBI compliance certificate for Q4FY26 to BSE Limited on April 10, 2026. The company's RTA, Bigshare Services Private Ltd., confirmed that Regulation 74(5) is not applicable as the entire shareholding remains in demat form with no rematerialisation or dematerialisation requests during the quarter. This submission fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018.
Vanta Bioscience Limited Responds to BSE Inquiry on Share Price Movement
Mar 11, 2026
Vanta Bioscience Appoints Ms. Pooja Kothari as Company Secretary and Compliance Officer
Jan 30, 2026
Vanta Bioscience Faces Insolvency Application Over Unpaid Salary Claims
Sep 05, 2025
Vanta Bioscience Reports Significant Losses for FY2025 Amid Revenue Decline
Aug 01, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO